Embotrap: payments to doctors
Payments that named Embotrap as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.9M
- Providers
- 1,269
- Transactions
- 6,025
- Average per transaction
- $311
The per-transaction average — $311 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,269 providers the average total is $1,474, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Medical Device Business Services, Inc. | $1,665,152 | 89.0% |
| Johnson & Johnson | $203,165 | 10.9% |
| Johnson And Johnson International | $1,650 | 0.1% |
| Biosense Webster, Inc. | $1,021 | 0.1% |